Bristol-Myers Squibb Co. (BMY) Tops Q2 EPS by 4c
Tweet
Share
E-mailGet Alerts BMY Hot Sheet
Price: $48.93 +1.30%
Revenue Growth %: +1.5%
Financial Fact:
Net Earnings Attributable to Bristol-Myers Squibb Company: 1.2B
Today's EPS Names:
MAXN, CSTR, ACU, More
Revenue Growth %: +1.5%
Financial Fact:
Net Earnings Attributable to Bristol-Myers Squibb Company: 1.2B
Today's EPS Names:
MAXN, CSTR, ACU, More
Join SI Premium – FREE
Bristol-Myers Squibb Co. (NYSE: BMY) reported Q2 EPS of $0.48, $0.04 better than the analyst estimate of $0.44. Revenue for the quarter came in at $3.89 billion versus the consensus estimate of $3.85 billion.
Bristol-Myers Squibb Co. reaffirmed FY2014 guidance.
For earnings history and earnings-related data on Bristol-Myers Squibb Co. (BMY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Growth isn't weak enough to truly undercut inflation pressures - BMO
- 'A moment of truth' for Tesla and Musk is here - Wedbush
- Super Micro Computer (SMCI) Falls 6%
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
